Rubric Capital Management (New York)’s Roivant Sciences ROIV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$139M	Sell	5,000,000 -4,000,000	-44%	-$103M	1.47%	17
2025 Q4	$195M	Sell	9,000,000 -11,000,000	-55%	-$217M	2.34%	10
2025 Q3	$303M	Sell	20,000,000 -370,336	-2%	-$4.58M	3.41%	7
2025 Q2	$230M	Buy	20,370,336 +2,603,260	+15%	+$28.2M	3.47%	6
2025 Q1	$179M	Sell	17,767,076 -2,232,924	-11%	-$24.1M	3.21%	7
2024 Q4	$237M	Sell	20,000,000 -2,400,000	-11%	-$28.4M	3.04%	8
2024 Q3	$258M	Sell	22,400,000 -600,000	-3%	-$6.83M	4.21%	3
2024 Q2	$243M	Buy	23,000,000 +3,000,000	+15%	+$32.9M	6.37%	2
2024 Q1	$211M	Buy	20,000,000 +1,000,000	+5%	+$10.8M	6.23%	3
2023 Q4	$213M	Buy	19,000,000 +8,500,000	+81%	+$82.8M	4.43%	2
2023 Q3	$123M	Buy	10,500,000 +6,963,562	+197%	+$78.7M	4.6%	5
2023 Q2	$35.6M	Sell	3,536,438 -2,063,562	-37%	-$18.5M	1.52%	28
2023 Q1	$41.3M	Buy	5,600,000 +2,600,000	+87%	+$21.4M	1.07%	21
2022 Q4	$24M	Buy	+3,000,000	New	+$16.7M	1.05%	32